Abstract: According to one aspect, a power storage system may include an enclosure, and one or more modules disposed in the enclosure. Each of the one or more modules may include a plurality of electrochemical cells electrically coupled to one another, each one of the plurality of electrochemical cells including an oxygen evolution electrode (OEE), an anode, a gas diffusion electrode (GDE), an electrolyte, and a vessel and, within the vessel, the OEE, the anode, and the GDE at least partially immersed in the electrolyte.

Abstract: The invention provides a partial power DC-DC converter with controllable topology, comprising: a galvanically isolated DC-DC converter having a positive and negative input; a positive and negative output; a DC voltage input electrically connected to said positive input of the DC-DC converter; an input reference; a DC voltage output electrically connected to said positive output of the DC-DC converter; an output reference electrically connected to said input reference; said partial power DC-DC converter additionally comprising: a first switch for selectively connecting said positive input to said negative output of the DC-DC converter; a second switch for selectively connecting said negative input of the DC-DC converter to said input reference; a third switch for selectively connecting said negative output of the DC-DC converter to said output reference; and a fourth switch for selectively connecting said positive output to said negative input of the DC-DC converter.

Abstract: The invention provides a partial power DC-DC converter with controllable topology comprising: a galvanically isolated DC-DC converter having a positive input, a negative input, a positive output, and a negative output; a first DC voltage input electrically connected to said negative output of the DC-DC converter; an input reference; a first DC voltage output electrically connected to said positive output of the DC-DC converter; and an output reference electrically connected to said input reference and said negative input of the DC-DC converter; wherein said partial power DC-DC converter additionally comprises: a first switch arranged to selectively connect said first DC voltage input to said positive input of the DC-DC converter; and a second switch arranged to selectively connect said positive output of the DC-DC converter to said positive input of the DC-DC converter.

Abstract: Described is a new partial power converter (PPC) for the DC-DC stage of rapid-charging stations for electric vehicles (EV). The proposed converter manages only a fraction of the total power delivered from the grid to the battery, which increases the general efficiency of the system and the power density while potentially reducing the cost of the charger. The proposed topology is based on a switched capacitor between the AC terminals of a bridge converter H and does not require high-frequency isolation transformers in order to provide a source of controllable voltage between the CC link and the battery. The proposed concept can be implemented by using interposed power cells, which can improve energy quality, reduce the size of the inductor, and allow scalability for chargers of higher nominal power.

Abstract: Flavonoids that are isolated from plant material of the genus Cecropia can be used to perturb G-protein coupled receptors in a mammalian cell. In some instances, one or more flavonoids may interact with one or more of the G-protein coupled receptors to transiently increase the concentration of cytosolic calcium. Administration of the isolated flavonoids can be used to treat hypertension, to protect the integrity of blood vessels and related conditions.

Abstract: Described is a new partial power converter (PPC) for the DC-DC stage of rapid-charging stations for electric vehicles (EV). The proposed converter manages only a fraction of the total power delivered from the grid to the battery, which increases the general efficiency of the system and the power density while potentially reducing the cost of the charger. The proposed topology is based on a switched capacitor between the AC terminals of a bridge converter H and does not require high-frequency isolation transformers in order to provide a source of controllable voltage between the CC link and the battery. The proposed concept can be implemented by using interposed power cells, which can improve energy quality, reduce the size of the inductor, and allow scalability for chargers of higher nominal power.

Abstract: Flavonoids that are isolated from plant material of the genus Cecropia can be used to perturb G-protein coupled receptors in a mammalian cell. In some instances, one or more flavonoids may interact with one or more of the G-protein coupled receptors to transiently increase the concentration of cytosolic calcium. Administration of the isolated flavonoids can be used to treat hypertension, to protect the integrity of blood vessels and related conditions.

Abstract: Flavonoids that are isolated from plant material of the genus Cecropia can be used to perturb G-protein coupled receptors in a mammalian cell. In some instances, one or more flavonoids may interact with one or more of the G-protein coupled receptors to transiently increase the concentration of cytosolic calcium. Administration of the isolated flavonoids can be used to treat hypertension, to protect the integrity of blood vessels and related conditions.

Abstract: Flavonoids that are isolated from plant material of the genus Cecropia can be used to perturb G-protein coupled receptors in a mammalian cell. In some instances, one or more flavonoids may interact with one or more of the G-protein coupled receptors to transiently increase the concentration of cytosolic calcium. Administration of the isolated flavonoids can be used to treat hypertension, to protect the integrity of blood vessels and related conditions.

Abstract: An adhesive composition includes one or more polymerizable cyanoacrylate monomers, a polymerization initiator and a polymerization accelerator for the one or more polymerizable cyanoacrylate monomers. A system for treating living tissue includes a first reservoir containing one or more polymerizable cyanoacrylate monomers, a second reservoir in a non-contacting relationship with the first reservoir containing a polymerization initiator and accelerator for the one or more polymerizable cyanoacrylate monomers, and an applicator capable of combining the polymerizable cyanoacrylate monomer and the polymerization initiator and accelerator to form an adhesive composition and then applying the adhesive composition to living tissue. The initiator may be a quaternary ammonium salt, and the accelerator may be a trihydroxy tertiary amine.

Abstract: An adhesive composition includes one or more polymerizable cyanoacrylate monomers, a polymerization initiator and a polymerization accelerator for the one or more polymerizable cyanoacrylate monomers. A system for treating living tissue includes a first reservoir containing one or more polymerizable cyanoacrylate monomers, a second reservoir in a non-contacting relationship with the first reservoir containing a polymerization initiator and accelerator for the one or more polymerizable cyanoacrylate monomers, and an applicator capable of combining the polymerizable cyanoacrylate monomer and the polymerization initiator and accelerator to form an adhesive composition and then applying the adhesive composition to living tissue. The initiator may be a quaternary ammonium salt, and the accelerator may be a trihydroxy tertiary amine.

Abstract: A method of treating or preventing tinea pedis, commonly known as Athlete's Foot, includes applying a polymerizable monomer adhesive composition to an area of skin afflicted with or susceptible to tinea pedis, optionally with at least one of an additional anti-fungal agent or a foot care additive, and allowing the polymerizable monomer composition to polymerize to form a polymer film over the area of skin.

Abstract: An applicator for dispensing a polymerizable or cross-linkable material includes an outer container, an inner container disposed within the outer container and containing a polymerizable or cross-linkable material, and a rate modifier for the polymerizable or cross-linkable material coated on an outer surface of the inner container. The rate modifier modifies a polymerization or cross-linking rate when the polymerizable or cross-linkable monomer material contacts the rate modifier upon opening of the inner container. The polymerizable and/or cross-linkable material may be applied to a variety of substrates.

Abstract: A method of sterilizing a polymerizable monomeric adhesive composition includes: providing a polymerizable monomeric adhesive composition in a container, the polymerizable monomeric adhesive composition including a polymerizable 1,1-disubstituted ethylene monomer and at least one stabilizer; holding the composition in the container for a pre-determined amount of time, which is sufficient to inhibit or eliminate polymerization of the monomer during or immediately after sterilization, before sterilizing the composition; and sterilizing the polymerizable monomeric adhesive composition inside the container.

Abstract: An applicator for dispensing compositions includes a crushable ampoule covered with a barrier material that serves as a protective barrier. The applicator can also include a body made of a flexible material that holds at least one crushable ampoule. The protective barrier protects the user's fingers from puncture by shards created during breakage of the crushable ampoule.

Abstract: A combination includes a pipette-shaped container formed from a polymeric material selected from polyethylene terephthalate, high density polyethylene, low density polyethylene, and mixtures thereof, and a 1,1 -disubstituted ethylene monomer adhesive composition sealed in the pipette-shaped container prior to dispensing the material.

Abstract: An adhesive composition includes a polymerizable adhesive monomer, at least one vapor phase stabilizer, and at least one liquid phase stabilizer. The combination of at least one vapor phase stabilizer and at least one liquid phase stabilizer provides superior stabilization and shelf-life for the monomer composition. The stabilized adhesive composition provides superior performance and shelf-life and can be sterilized without significant polymerization of the monomer.

Abstract: A method of treating or preventing tinea pedis, commonly known as Athlete's Foot, includes applying a polymerizable monomer adhesive composition to an area of skin afflicted with or susceptible to tinea pedis, optionally with at least one of an additional anti-fungal agent or a foot care additive, and allowing the polymerizable monomer composition to polymerize to form a polymer film over the area of skin.

Abstract: An applicator for dispensing compositions includes a crushable ampoule covered with a barrier material that serves as a protective barrier. The applicator can also include a body made of a flexible material that holds at least one crushable ampoule. The protective barrier protects the user's fingers from puncture by shards created during breakage of the crushable ampoule.

Abstract: A method of sterilizing a polymerizable monomeric adhesive composition includes: providing a polymerizable monomeric adhesive composition in a container, the polymerizable monomeric adhesive composition including a polymerizable 1,1 -disubstituted ethylene monomer and at least one stabilizer; holding the composition in the container for a pre-determined amount of time, which is sufficient to inhibit or eliminate polymerization of the monomer during or immediately after sterilization, before sterilizing the composition; and sterilizing the polymerizable monomeric adhesive composition inside the container.